Understanding Non‐Inferiority Trials – A Different Type of Evidence

Publisher： John Wiley & Sons Inc

E-ISSN： 2055-2335|41|1|16-17

ISSN： 1445-937x

Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.41, Iss.1, 2011-03, pp. : 16-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Ratio Test in Active Control Non-Inferiority Trials with a Time-to-Event Endpoint

By Wang Yong-Cheng  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 2, 2006-03 ,pp. : 151-164

Taylor & Francis Ltd

Access to resources Recommend Favorite

Two New Covariate Adjustment Methods for Non-Inferiority Assessment of Binary Clinical Trials Data

By Hou Yan  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 1, 2011-01 ,pp. : 77-93

Taylor & Francis Ltd

Access to resources Recommend Favorite

Design of Vaccine Equivalence/Non-Inferiority Trials with Correlated Multiple Binomial Endpoints

By Kong L.  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 4, 2006-07 ,pp. : 555-572

Taylor & Francis Ltd

Access to resources Recommend Favorite

Statistical Considerations for NonInferiority/Equivalence Trials in Vaccine Development

By Wang W. W. B.   Mehrotra D. V.   Chan I. S. F.   Heyse J. F.  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 4, 2006-07 ,pp. : 429-441

Taylor & Francis Ltd

Access to resources Recommend Favorite

The Adjustment of the Type I Error Rate in Noninferiority Trials with -Margin Approach: Each of Two Different New Drugs is Approved with Two Independent Trials with the Same Active Control

By Kang Seung-Ho   Ryu Yuman  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 3, 2011-05 ,pp. : 498-510

Taylor & Francis Ltd

Access to resources Recommend Favorite